Showing 1 - 9 results of 9 for search 'Warren, AY', query time: 0.04s
Refine Results
-
1
Imaging tumor lactate is feasible for identifying intermediate-risk prostate cancer patients with postsurgical biochemical recurrence by Sushentsev, N, Hamm, G, Richings, J, McLean, MA, Menih, IH, Ayyappan, V, Mills, IG, Warren, AY, Gnanapragasam, VJ, Barry, ST, Goodwin, RJA, Gallagher, FA, Barrett, T
Published 2023Journal article -
2
Independence of HIF1a and androgen signaling pathways in prostate cancer by Tran, MGB, Bibby, BAS, Yang, L, Lo, F, Warren, AY, Shukla, D, Osborne, M, Hadfield, J, Carroll, T, Stark, R, Scott, H, Ramos-Montoya, A, Massie, C, Maxwell, P, West, CML, Mills, IG, Neal, DE
Published 2020Journal article -
3
Metabolic imaging across scales reveals distinct prostate cancer phenotypes by Sushentsev, N, Hamm, G, Flint, L, Birtles, D, Zakirov, A, Richings, J, Ling, S, Tan, JY, McLean, MA, Ayyappan, V, Horvat Menih, I, Brodie, C, Miller, JL, Mills, IG, Gnanapragasam, VJ, Warren, AY, Barry, ST, Goodwin, RJA, Barrett, T, Gallagher, FA
Published 2024Journal article -
4
Hyperpolarised 13C-MRI identifies the emergence of a glycolytic cell population within intermediate-risk human prostate cancer by Sushentsev, N, McLean, MA, Warren, AY, Benjamin, AJV, Brodie, C, Frary, A, Gill, AB, Jones, J, Kaggie, JD, Lamb, BW, Locke, MJ, Miller, JL, Mills, IG, Priest, AN, Robb, FJL, Shah, N, Schulte, RS, Graves, MJ, Gnanapragasam, VJ, Brindle, KM, Barrett, T, Gallagher, FA
Published 2022Journal article -
5
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates by Buhigas, C, Warren, AY, Leung, W-K, Whitaker, HC, Luxton, HJ, Hawkins, S, Kay, J, Butler, A, Xu, Y, Woodcock, DJ, Merson, S, Frame, FM, Sahli, A, Abascal, F, Martincorena, I, Bova, GS, Foster, CS, Campbell, P, Maitland, NJ, Neal, DE, Massie, CE, Lynch, AG, Eeles, RA, Cooper, CS, Wedge, DC, Brewer, DS, Mills, IG
Published 2022Journal article -
6
HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer by Ross-Adams, H, Ball, S, Lawrenson, K, Halim, S, Russell, R, Wells, C, Strand, SH, Ørntoft, TF, Larson, M, Armasu, S, Massie, CE, Asim, M, Mortensen, MM, Borre, M, Woodfine, K, Warren, AY, Lamb, AD, Kay, J, Whitaker, H, Ramos-Montoya, A, Murrell, A, Sørensen, KD, Fridley, BL, Goode, EL, Gayther, SA, Masters, J, Neal, DE, Mills, IG
Published 2016Journal article -
7
Molecular subgroup of primary prostate cancer presenting with metastatic biology. by Walker, SM, Knight, LA, McCavigan, AM, Logan, GE, Berge, V, Sherif, A, Pandha, H, Warren, AY, Davidson, C, Uprichard, A, Blayney, JK, Price, B, Jellema, GL, Steele, CJ, Svindland, A, McDade, SS, Eden, CG, Foster, C, Mills, IG, Neal, DE, Mason, MD, Kay, EW, Waugh, DJ, Harkin, DP, Watson, RW, Clarke, NW, Kennedy, RD
Published 2017Journal article -
8
The ProtecT trial: Analysis of the patient cohort, baseline risk stratification and disease progression by Young, GJ, Davis, M, Turner, EL, Martin, RM, Goepel, JR, Varma, M, Griffiths, DF, Grigor, K, Mayer, N, Warren, AY, Bhattarai, S, Dormer, J, Mason, M, Staffurth, J, Walsh, E, Rosario, DJ, Catto, JW, Neal, DE, Donovan, JL, Hamdy, FC, Bollina, P, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Rowe, E
Published 2020Journal article -
9
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer. by Asim, M, Tarish, F, Zecchini, HI, Sanjiv, K, Gelali, E, Massie, CE, Baridi, A, Warren, AY, Zhao, W, Ogris, C, McDuffus, L-A, Mascalchi, P, Shaw, G, Dev, H, Wadhwa, K, Wijnhoven, P, Forment, JV, Lyons, SR, Lynch, AG, O'Neill, C, Zecchini, VR, Rennie, PS, Baniahmad, A, Tavaré, S, Mills, IG, Galanty, Y, Crosetto, N, Schultz, N, Neal, D, Helleday, T
Published 2017Journal article